Stuart Nancy

Stuart Nancy is listed in filings as Director at KalVista Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Oct 2, 2025, including 2 public disclosures. Recent filings connect the profile to KalVista Pharmaceuticals, Inc. (KALV). The current snapshot covers public activity from Oct 4, 2024 to Oct 2, 2025. Reported amounts are shown as $115.4K to $361.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.